Xvivo Perfusion AB (XVIPF)
21.80
0.00 (0.00%)
USD |
OTCM |
Oct 08, 16:00
Xvivo Perfusion Gross Profit Margin (Quarterly) : 63.23% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 63.23% |
| March 31, 2026 | 63.69% |
| December 31, 2025 | 64.73% |
| September 30, 2025 | 66.57% |
| June 30, 2025 | 65.44% |
| March 31, 2025 | 66.12% |
| December 31, 2024 | 61.20% |
| September 30, 2024 | 66.38% |
| June 30, 2024 | 67.02% |
| March 31, 2024 | 63.79% |
| December 31, 2023 | 56.49% |
| September 30, 2023 | 64.15% |
| June 30, 2023 | 66.09% |
| March 31, 2023 | 65.77% |
| December 31, 2022 | 63.71% |
| September 30, 2022 | 60.92% |
| June 30, 2022 | 60.90% |
| March 31, 2022 | 59.72% |
| December 31, 2021 | 64.54% |
| September 30, 2021 | 54.63% |
| June 30, 2021 | 64.32% |
| March 31, 2021 | 70.18% |
| December 31, 2020 | 63.80% |
| September 30, 2020 | 69.76% |
| June 30, 2020 | 65.35% |
| Date | Value |
|---|---|
| March 31, 2020 | 60.42% |
| December 31, 2019 | 62.53% |
| September 30, 2019 | 58.90% |
| June 30, 2019 | 63.09% |
| March 31, 2019 | 67.43% |
| December 31, 2018 | 68.64% |
| September 30, 2018 | 65.31% |
| June 30, 2018 | 63.12% |
| March 31, 2018 | 61.60% |
| December 31, 2017 | 67.38% |
| September 30, 2017 | 67.16% |
| June 30, 2017 | 69.32% |
| March 31, 2017 | 62.74% |
| December 31, 2016 | 66.23% |
| September 30, 2016 | 66.02% |
| June 30, 2016 | 63.09% |
| March 31, 2016 | 63.10% |
| December 31, 2015 | 65.91% |
| September 30, 2015 | 61.02% |
| June 30, 2015 | 64.86% |
| March 31, 2015 | 52.40% |
| December 31, 2014 | 65.76% |
| September 30, 2014 | 65.86% |
| June 30, 2014 | 79.09% |
| March 31, 2014 | 76.00% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Getinge AB | 49.35% |
| Paxman AB | 3.65% |
| Enovis Corp. | 54.51% |
| Edwards Lifesciences Corp | 78.09% |
| IDEXX Laboratories, Inc. | 64.07% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 4.23% |
| Return on Assets | 3.72% |
| Return on Invested Capital | 4.00% |
| Profit Margin (Quarterly) | 6.81% |
| Operating Margin (Quarterly) | 9.22% |
| Return on Net Operating Assets | 4.62% |